Loading…
Isotopia Molecular Imaging and Alpha-9 Theranostics signed a global clinical supply agreement for Isotopia's no-carrier-added lutetium-177 for the preclinical and clinical development of Alpha-9's radiopharmaceutical pipeline.
Eckert & Ziegler has signed a clinical supply agreement with Alpha-9 Theranostics to supply its medical radioisotope Lutetium-177 (n.c.a. 177Lu) for the clinical development of Alpha-9's investigational drugs for solid and hematologic malignancies.